Evidence map›Paper›PMID 24683447›Full record

ArticleFrontline gastroenterology2014

Hepatitis B in pregnancy.

Jessica Katharine Dyson, Julia Waller, Andrena Turley, Enid Michael, Samuel Moses, Manoj Valappil, Mark Hudson, Margaret Bassendine, Stuart McPherson

Open access · hybridAbstract read
In one paragraph

Article in Frontline gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Viral hepatitis vaccination during pregnancy.Human vaccines & immunotherapeutics · 2016
    Review
  7. Chronic hepatitis B infection in pregnancy.World journal of hepatology · 2015
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Jessica Katharine DysonLiver Unit , Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust , Newcastle upon Tyne , UK.
Julia WallerHealth Protection Agency , Newcastle upon Tyne , UK.
Andrena TurleyDepartment of Obstetrics , Royal Victoria Infirmary, Newcastle Upon Tyne Hospitals NHS Trust , Newcastle upon Tyne , UK.
Enid MichaelDepartment of Obstetrics , Royal Victoria Infirmary, Newcastle Upon Tyne Hospitals NHS Trust , Newcastle upon Tyne , UK.
Samuel MosesHealth Protection Agency , Newcastle upon Tyne , UK ; Institute of Cellular Medicine, Newcastle University , Newcastle upon Tyne , UK.
Manoj ValappilHealth Protection Agency , Newcastle upon Tyne , UK ; Institute of Cellular Medicine, Newcastle University , Newcastle upon Tyne , UK.
Mark HudsonLiver Unit , Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust , Newcastle upon Tyne , UK ; Institute of Cellular Medicine, Newcastle University , Newcastle upon Tyne , UK.
Margaret BassendineLiver Unit , Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust , Newcastle upon Tyne , UK ; Institute of Cellular Medicine, Newcastle University , Newcastle upon Tyne , UK.
Stuart McPhersonLiver Unit , Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust , Newcastle upon Tyne , UK ; Institute of Cellular Medicine, Newcastle University , Newcastle upon Tyne , UK.
Health Protection Scotland · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GBRoyal Victoria Infirmary · GBFreeman Hospital · GBNewcastle University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveVertical transmission of the hepatitis B virus (HBV) is the commonest mode of infection and can be prevented with immunoprophylaxis of the infant and antiviral therapy in the mother. Our aim was to review a cohort of subjects with HBV in pregnancy to determine the prevalence of active disease or high HBV-DNA levels that required treatment to prevent transmission, and to review the management of mothers and infants.

methodsA retrospective case-note review was conducted of all the HBV-infected pregnant women and their infants who attended the Newcastle obstetric services from 2007 to 2011.

resultsThere were 113 pregnancies in 81 women (median age 28 years; 15% hepatitis B e antigen (HBeAg) positive) during 2007-11. 71% of mothers were first diagnosed with HBV during pregnancy. The mothers were born in 28 different countries. 69% of mothers had an HBV-DNA level less than 2000 IU/mL and 13% had HBV-DNA levels greater than 1.0×10

conclusionsOne in six women had active HBV requiring treatment or high HBV-DNA levels that would benefit from antiviral treatment to reduce the transmission risk. HBIG was administered appropriately but completion of the vaccination course was suboptimal.

Indexed as

ANTIVIRAL THERAPYCHRONIC VIRAL HEPATITISHEPATITIS BLIVER DISEASE IN PREGNANCY

Identifiers

PMID24683447
PMCPMC3963528
OpenAlexW2158623444

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.